Celldex Therapeutics (CLDX) Research & Development (2016 - 2025)
Historic Research & Development for Celldex Therapeutics (CLDX) over the last 16 years, with Q3 2025 value amounting to $62.9 million.
- Celldex Therapeutics' Research & Development rose 3903.41% to $62.9 million in Q3 2025 from the same period last year, while for Sep 2025 it was $216.7 million, marking a year-over-year increase of 4736.43%. This contributed to the annual value of $163.5 million for FY2024, which is 3858.88% up from last year.
- According to the latest figures from Q3 2025, Celldex Therapeutics' Research & Development is $62.9 million, which was up 3903.41% from $54.2 million recorded in Q2 2025.
- In the past 5 years, Celldex Therapeutics' Research & Development ranged from a high of $62.9 million in Q3 2025 and a low of $12.4 million during Q2 2021
- In the last 5 years, Celldex Therapeutics' Research & Development had a median value of $26.8 million in 2023 and averaged $30.9 million.
- Its Research & Development has fluctuated over the past 5 years, first skyrocketed by 876.44% in 2021, then skyrocketed by 6778.08% in 2022.
- Quarter analysis of 5 years shows Celldex Therapeutics' Research & Development stood at $14.7 million in 2021, then surged by 56.01% to $22.9 million in 2022, then skyrocketed by 32.87% to $30.4 million in 2023, then surged by 54.27% to $46.9 million in 2024, then skyrocketed by 34.07% to $62.9 million in 2025.
- Its Research & Development stands at $62.9 million for Q3 2025, versus $54.2 million for Q2 2025 and $52.6 million for Q1 2025.